There is an increasing interest in IL-34 and CSF-1, where IL-34 overexpression was observed in inflammatory conditions including Sjögren’s syndrome, whereas overexpression of IL-34 and CSF-1 was reported for RA and IBD. This evidence concerns the gene CSF1 and inflammatory bowel disease.